POLB

Poolbeg Pharma #POLB – agrees option agreement with UCD December 7, 2021 – Posted in: Poolbeg Pharma (POLB)

  #POLB featured in the Irish Times following the recently announced Option Agreement to licence #MelioVac with University College Dublin Potential to generate significant returns for investors Contributing to the global response to the threat of infectious diseases https://www.irishtimes.com/business/health-pharma/poolbeg-pharma-agrees-option-agreement-with-ucd-1.4747770

Continue reading

Irish Times – Open Orphan seals deal that could net more than €11.6m March 6, 2020 – Posted in: Open Orphan (ORPH)

by Colin Gleeson Dublin-listed pharma group announces contract with European biotech company Dublin-listed pharma services company Open Orphan has announced the signing of a new contract with a European biotech company that could yield it more than £10 million in revenue this year. Open Orphan, a European-focussed, rare and orphan drug consulting services platform, informed the Irish stock exchange of the deal for the provision of an respiratory syncytial virus (RSV) human challenge study on Friday. The…

Continue reading